Journal of Preventive Veterinary Medicine

The Korean Society of Preventive Veterinary Medicine (한국예방수의학회)
권호 표지

Current situations of human brucellosis in Korea and research tendency

사람 브루셀라증의 국내 발생 및 연구 동향

Choi, Young-Sil;Lee, Joo-Sun;Park, Sang-Hee;Shim, Soo-Kyoung;Hwang, Kyu-Jam;Park, Mi-Yeoun
최영실;이주선;박상희;심수경;황규잠;박미연

  • Published : 20070600
⟨ Previous Next ⟩

Abstract

Brucellosis became a major zoonosis with a dramatic increase in case incidence since it was classifiedand controlled as type 3 notifiable disease in Communicable Disease Prevention Act in August 2000.Based on host preference, BruceHa genus is divided into eight species. Among these species, BruceUamelitensis, and B. suis are pathogenic to humans. B. abortus is less virulent, but it nevertheless causesserious social- economic losses in endemic areas through human exposure to aborted calves. Increasingcases of bmcellosis in cattle have occurred in Korea with the large- scale introduction of under screenedKorean native cattle and the herd test that has been conducted since 2004. Accordingly the screening testwas reinforced, the number of human brucellosis has also sharply increased from 16 cases in 2003 to215(Provisiona1 statics) in 2006. A total of 437 cases were reported from 2002 to 2006. By occupation,livestock industry workers, veterinarians, and others including animal by product handlers, lab workeraccounted for 382(87.5%), 44(10%), 11(2.5%) cases, respectively. 44 human isolates were identified B.abortus biovar 1 by AMOS PCR. But 20% of 44 cases were asymptomatic, demonstrating that theinfection can easily develop into chronic conditions. Human brucellosis in K-orea was mainly concernedwith livestock industry and infection by unprotected contact was major route of transmission.

Keywords

References

  1. 농림부, 국립수의과학검역원: 가축전염병발생통계,2006
  2. 보건복지부, 국립보건원: 전염병예방법령, 2001
  3. 박만석, 우영석, 이민정, 섬수경, 이혜경, 최영 설, 이우홍, 김기현, 박미연. 국내 브루셀라균에 감염된 환자 1예. 감염과 화학요법, 2003, 35, 461-466
  4. 임현술, 송영구, 유한상, 박미연, 김종완. 브루셀라증 개요. 한국역학회지, 2005, 27, 26-36
  5. 정문현. 브루셀라증. 감염, 1994, 26, 409-414
  6. 질병관리본부. 전염병 발생 통계,2006
  7. 질병관리본부. 법정 전염병 신고. 보고 기준. 서 울,2007.
  8. 질병관리본부. 국내 브루셀라증, 2000년 1월-2004년 3월. 감염병 발생정보, 2004, 15(4), 6570
  9. Baldi, P. C., Miguel, S. E., Fossati, C. A. and Wallach, J. C. Serological follow-up of human brucellosis by measuring IgG antibodies to lipopolysaccharide and cytoplasmic proteins of Brucella species. Clin Infect Dis, 1996, 22, 446-455 https://doi.org/10.1093/clinids/22.3.446
  10. Betsy, J. B., Darla, R. E., Steven. C. O. and Allen, E. J. Evaluation of the Brucella abortus species-specific polymerase chain reaction assay, an improved version of the Brucella AMOS polymerase chain reaction assay for cattle. J Vet Diagn Invest, 2003, 15, 374-378 https://doi.org/10.1177/104063870301500413
  11. Biosafty in microbiological and biomedical laboratories, 4th ed. Washington DC, United States Department of Health and Human services/ Centers for Diseases Control and Preventionl National Institutes of Health, 1999
  12. CDC. Basic laboratory protocols for the presumptive identification of Brucella species, 2001
  13. CDC. Case definition of brucellosis. MMWR, 1997, 46, 1-55
  14. CDC. Suspected brucellosis case prompts investigation of possible bioterrorism-related activity (New Hampshire and Massachusetts, 1999). MMWR, 2000, 49, 509-512
  15. Christelle, M. R., Hortensia G. R., Renato, L. S., Pillip, D. B., Terry, L. T. L., Garry Adams and Rene'e, M. T. Brucella requires a functional Type IV secretion system to elicit innate immune reponses in mice. Cellular Microbiology, 2007, 1-19
  16. Corbel, M. J. Brucellosis: an overview. Emerging Infect Dis, 1997,3, 213-21 https://doi.org/10.3201/eid0302.970219
  17. DelVecchio, V. G., Kapatral, V., Redkar, R. J., Patra, G., Mujer, G., Los T., Ivanova, N., Aderson, I., Bhattacharyya, A., Lykids, A., Renzik, G., Jablonski, L., Larsen, N., D' Souza, M., Bernal, A., Mazur, M., Goltsman, E., Selkov, E., Elzer, P. H., Hagius, S., O'Callaghan, D., Letesson, J. J., Haselkorn, R., Kyrpides, N. and Overbeek R. The genome sequence of the facultative intracellular pathogen Brucella melitensis. Proceedings of the National Academy of Sciences of United of America, 2002, 99, 443-448
  18. Dogana, M. and Aygen, B. Human brucellosis: an overview. Int J Infect Dis, 2003, 7(3), 173-178 https://doi.org/10.1016/S1201-9712(03)90049-X
  19. Gireesh, R., Linda, E., Angie, M., Erik, P., Qiqi, Y., Jerome, H. and Gary, S. Brucella: functional genomics and host-pathogen interactions. Animal Health Reaserch Reviews, 2007, 7, 1-11
  20. Kaufmann, A. F., Meltzer, M. L. and Schmid, G. P. The economic mpact of bioterrorist attack: are prevention and postattack intervention programs justifiable? Emerg Infect Dis, 1997, 3, 83-94 https://doi.org/10.3201/eid0302.970201
  21. Memish, Z., Mah, M. W., Mahmound, S. A,. Shaalan, M. A. and Khan, M. Y. Brucella bacteremia: Clinical and laboratory observations in 160 patients. Journal of Infection, 2000, 40, 59-63 https://doi.org/10.1053/jinf.1999.0586
  22. Park, M. Y., Lee, C. S., Choi, Y. S., Park, S. J., Lee, J. S. and Lee, H. B. A sporadic outbreak of human brucellosis in Korea. J Korean Med. Sci, 2005, 20, 505-8
  23. Navarro, E., Escribano, J., Fernandez, J. and Solera, J. Comparison of three different PCR methods for detection of Brucella spp. in human blood samples. FEMS Immunl Med Microbiol, 2002, 34, 147-151 https://doi.org/10.1111/j.1574-695X.2002.tb00616.x
  24. Pablo, C. B., Miguel, S. E,. Fossati, C. A and Wallach, J. C. Serological follow-up of human brucellosis by measuring IgG antibodies to lipopolysaccharide and cytoplasmic proteins of Brucella species. Clin Infect Dis, 1996, 22, 446-455 https://doi.org/10.1093/clinids/22.3.446
  25. Panbio. Brucella IgM and IgG test, Revised 13/01/00 BAMINS.DOC
  26. Rabab, A. A., Mohammad, A., Abdul, R. A., Mohammad, B. A. and Nafisa, A. Evaluation of PCR, culture and serology for the diagnosis of acute human Brucellosis. Annals of Saudi Medicine, 2000, 20, 224-228 https://doi.org/10.5144/0256-4947.2000.224
  27. Sallstrom, B. and Aderson, S. G. Genome reduction in the alpha-Proteobacteria. Current opinion in Microbiology, 2005, 8, 579-585 https://doi.org/10.1016/j.mib.2005.08.002
  28. Sauret, J. M. and Natalia, V. Human Brucellosis. J Am Board Fam Pract, 2002 15,401-406
  29. Solera, J., Rodriguez-Zapata, M., Geijo, P., Largo, J., Paulino, J., Saez, L., Martinez-Alfaro, E., Sanchez, L., Sepulveda, M. A. and Ruiz-Ribo, M. D. Doxycycline-rifarnpin versus Doxycycline-streptomycin in treatment of human brucellosis due to Brucella melitensis. Antimicrob Agents Chrother, 1995, 39, 2061-2067 https://doi.org/10.1128/AAC.39.9.2061
  30. Young, E. J. Serologic diagnosis of human brucellosis: analysis of 214 cases by agglutination tests and review of the literature. Rev Infect Dis, 1991, 13, 359-72 https://doi.org/10.1093/clinids/13.3.359
  31. WHO. Report of the WHO/FAO/OIE joint consultation on emerging zoonotic diseases. Geneva, 2004